This article was originally published in SRA
UK's NICE recommends use of statins in primary care
You may also be interested in...
The firm’s acute migraine treatment Nurtec ODT generated $65m in 2020 after launching a year ago. Biohaven aims for Nurtec to become the leader in what could be a $4bn-$5bn category in the US.
The Q-Collar is meant to work by improving blood flow to the brain, and has been shown to reduce signs of trauma from head impacts when playing sports.
The device can conduct laparoscopic hysterectomies, giving surgeons more mobility while leaving less scarring.